Document Detail

Tissue plasminogen activator in pediatric myocardial infarction.
MedLine Citation:
PMID:  10783412     Owner:  NLM     Status:  MEDLINE    
Children rarely present to emergency physicians during an acute myocardial infarction. However, this may occur in the setting of Kawasaki disease with thrombosed coronary aneurysms. We present the first case in which intravenous tissue plasminogen activator was used to successfully treat a 7-year-old child having an acute myocardial infarction caused by a thrombosed coronary aneurysm.
S Krendel; P Pollack; J Hanly
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Annals of emergency medicine     Volume:  35     ISSN:  0196-0644     ISO Abbreviation:  Ann Emerg Med     Publication Date:  2000 May 
Date Detail:
Created Date:  2000-05-18     Completed Date:  2000-05-18     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8002646     Medline TA:  Ann Emerg Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  502-5     Citation Subset:  AIM; IM    
Department of Emergency Medicine, University of Massachusetts Medical Center, Worcester, MA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Coronary Thrombosis / drug therapy
Dose-Response Relationship, Drug
Drug Administration Schedule
Electrocardiography / drug effects
Infusions, Intravenous
Mucocutaneous Lymph Node Syndrome / drug therapy
Myocardial Infarction / drug therapy*
Thrombolytic Therapy*
Tissue Plasminogen Activator / adverse effects,  therapeutic use*
Reg. No./Substance:
EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Report of the Task Force on Residency Training Information (1999-2000), American Board of Emergency ...
Next Document:  Clinical policy: critical issues in the evaluation and management of adult patients presenting with ...